The Leukemia & Lymphoma Society currently has 65 chapters across the United States and Canada and has dedicated $411 million to research since its inception in 1949. The Society is dedicated to being one of the top-rated voluntary health agencies in terms of dollars that directly fund the mission: 75% of the Society’s expenditures are directed to research, patient and community services, advocacy and education.

Between 1995 and 2004, the Society enjoyed tremendous growth including a 364 percent increase in revenue. In fact, during the same period, the Society's research funding increased 378 percent (from $8.6 million to $41.1 million). The good news is . .

• Cure rates for some forms of childhood leukemia have risen from 4% in 1960 to 84% today
• The Leukemia & Lymphoma Society funds more than 400 researchers in 11 countries and provides thousands of patients support through family support groups, website chats, free seminars and conferences, financial aid, and programs like "First Connection" where cancer patients are partnered with cancer survivors who provide support and advice.
• Our world-renowned SCOR research teams work together in complementary disciplines, each focused on accelerating the discover of breakthrough approaches for diagnosing and treating blood cancers

But we still have bad news . . .

• Leukemia, lymphoma and multiple myeloma are the major forms of blood-related cancers, with leukemia being a leading disease killer of children in America.
• Every nine minutes, another child or adult is expected to die from leukemia, lymphoma, or myeloma. This statistic represents 158 people each day, or seven people every hour.
• Lymphoma incidence rates have inexplicably increased by 71% between 1975 and 2000, the highest rate of increase for any cancer.
• Multiple myeloma is one of the top 10 leading causes of death among African Americans.
• An estimated 747,000 Americans are living with a blood cancers